公开(公告)号：WO2005118626A2

公开(公告)日：2005-12-15

申请号：PCT/EP2005/052457

申请日：2005-05-30

Applicant: INNOGENETICS N.V. ,  IDM PHARMA INC. ,  DEPLA, Erik ,  BUYSE, Marie-Ange ,  LASTERS, Ignace ,  DESMET, Johan ,  MAERTENS, Geert ,  BAKER, Denise ,  CHESNUT, Robert W. ,  NEWMAN, Mark ,  SETTE, Alessandro ,  SIDNEY, John ,  SOUTHWOOD, Scott

Inventor： DEPLA, Erik ,  BUYSE, Marie-Ange ,  LASTERS, Ignace ,  DESMET, Johan ,  MAERTENS, Geert ,  BAKER, Denise ,  CHESNUT, Robert W. ,  NEWMAN, Mark ,  SETTE, Alessandro ,  SIDNEY, John ,  SOUTHWOOD, Scott

IPC: C07K14/18

CPC classification number: C07K14/005 ,  A61K39/00 ,  A61K39/12 ,  A61K39/29 ,  A61K2039/55566 ,  A61K2039/57 ,  C12N2770/24222 ,  C12N2770/24234

Abstract: The present invention is directed to peptides, and nucleic acids encoding them, derived from the Hepatitis C Virus (HCV). The peptides are those which elicit a CTL and/or HTL response in a host. The invention is also directed to compositions and vaccines for prevention and treatment of HCV infection and diagnostic methods for detection of HCV exposure in patients.

Abstract translation: 本发明涉及衍生自丙型肝炎病毒（HCV）的肽和编码它们的核酸。 肽是在宿主中引起CTL和/或HTL应答的肽。 本发明还涉及用于预防和治疗HCV感染的组合物和疫苗以及用于检测患者中HCV暴露的诊断方法。

公开(公告)号：WO2004094454A3

公开(公告)日：2006-11-09

申请号：PCT/US2004011895

申请日：2004-04-16

Applicant: IDM PHARMA INC ,  FIKES JOHN D ,  ISHIOKA GLENN ,  SETTE ALESSANDRO ,  CHESNUT ROBERT W

Inventor： FIKES JOHN D ,  ISHIOKA GLENN ,  SETTE ALESSANDRO ,  CHESNUT ROBERT W

IPC: C07K5/00 ,  A61K38/00 ,  C07K20060101

CPC classification number: A61K39/0011 ,  A61K39/39 ,  A61K2039/55511 ,  A61K2039/55566 ,  A61K2039/57 ,  A61K2039/572 ,  A61K2039/70 ,  C07K7/06 ,  C07K14/47

Abstract: A peptide or composition comprising at least one HLA-A2 epitope or analog from CEA, HER2/neu, MAGE2, MAGE3, or p53.

Abstract translation: 包含至少一种HLA-A2表位或CEA，HER2 / neu，MAGE2，MAGE3或p53的类似物的肽或组合物。